Tumor immunity portrait: An AI-driven molecular predictor combining tumor microenvironment and tumor mutational burden for immune checkpoint inhibitor response prediction

被引：0
|
作者：
Shilo, Polina [1 ]
Tarasov, Artem [1 ]
Filatova, Anna [1 ]
Danilov, Konstantin [1 ]
Valiev, Ivan [1 ]
Kotlov, Nikita [1 ]
Brown, Jessica H. [1 ]
Ogloblina, Anna [1 ]
Bagaev, Alexander [1 ]
Fowler, Nathan [1 ]
机构：
[1] BostonGene Corp, Waltham, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14691
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
    Goodman, Aaron M.
    Kato, Shumei
    Bazhenova, Lyudmila
    Patel, Sandip P.
    Frampton, Garrett M.
    Miller, Vincent
    Stephens, Philip J.
    Daniels, Gregory A.
    Kurzrock, Razelle
    [J]. MOLECULAR CANCER THERAPEUTICS, 2017, 16 (11) : 2598 - 2608
  • [22] Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
    Sammons, Sarah
    Elliott, Andrew
    Barroso-Sousa, Romualdo
    Chumsri, Saranya
    Tan, Antoinette R.
    Sledge, George W.
    Tolaney, Sara M.
    Torres, Evanthia T. Roussos
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
    Sammons, Sarah
    Elliott, Andrew
    Force, Jeremy
    Chumsri, Saranya
    Anders, Carey
    Tan, Antoinette R.
    Magee, Daniel
    Zeng, Jia
    Korn, W. Michael
    Kahsraw, Mustafa
    Torres, Evanthia T. Roussos
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [24] Tumor assessment in immune checkpoint inhibitor therapy. Tumor response, progression and pseudoprogression
    Foller, S.
    Oppel-Heuchel, H.
    Grimm, M. -O.
    [J]. UROLOGE, 2018, 57 (11): : 1316 - 1325
  • [25] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
    Brown, Landon C.
    Zhu, Jason
    Desai, Kunal
    Kinsey, Emily
    Kao, Chester
    Lee, Yong Hee
    Pabla, Sarabjot
    Labriola, Matthew K.
    Tran, Jennifer
    Dragnev, Konstantin H.
    Tafe, Laura J.
    Dayyani, Farshid
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Glenn, Sean T.
    Nesline, Mary K.
    George, Saby
    Zibelman, Matthew
    Morrison, Carl
    Ornstein, Moshe C.
    Zhang, Tian
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [26] A clinical AI-driven multiplex immunofluorescence imaging pipeline to characterize tumor microenvironment heterogeneity
    Zarubin, Dmitry
    Belotskiy, Valeriy
    Xiang, Zhongmin
    Varlamova, Arina
    Ovcharov, Pavel
    Galkin, Ilia
    Polyakova, Margarita
    Svekolkin, Viktor
    Perelman, Grigory
    Bruttan, Maria
    Brown, Jessica H.
    Postovalova, Ekaterina
    Bagaev, Aleksander
    Fowler, Nathan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN PATIENTS WITH MICROSATELLITE INSTABLE AND HIGH TUMOR MUTATIONAL BURDEN PROSTATE CANCER
    Lenis, Andrew T.
    Ravichandran, Vignesh
    Hong Truong
    Reisz, Peter
    Nweji, Barbara
    Autio, Karen
    Morris, Michael
    Slovin, Susan
    Vargas, Hebert Alberto
    Laudone, Vincent
    Ehdaie, Behfar
    Reuter, Victor
    Viale, Agnes
    Schultz, Nikolaus
    Gopalan, Anuradha
    Donoghue, Mark
    Stopsack, Konrad
    Solit, David
    Abida, Wassim
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E411 - E411
  • [28] Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Valero, Cristina
    Lee, Mark
    Hoen, Douglas
    Weiss, Kate
    Kelly, Daniel W.
    Adusumilli, Prasad S.
    Paik, Paul K.
    Plitas, George
    Ladanyi, Marc
    Postow, Michael A.
    Ariyan, Charlotte E.
    Shoushtari, Alexander N.
    Balachandran, Vinod P.
    Hakimi, A. Ari
    Crago, Aimee M.
    Roche, Kara C. Long
    Smith, J. Joshua
    Ganly, Ian
    Wong, Richard J.
    Patel, Snehal G.
    Shah, Jatin P.
    Lee, Nancy Y.
    Riaz, Nadeem
    Wang, Jingming
    Zehir, Ahmet
    Berger, Michael F.
    Chan, Timothy A.
    Seshan, Venkatraman E.
    Morris, Luc G. T.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [29] Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Cristina Valero
    Mark Lee
    Douglas Hoen
    Kate Weiss
    Daniel W. Kelly
    Prasad S. Adusumilli
    Paul K. Paik
    George Plitas
    Marc Ladanyi
    Michael A. Postow
    Charlotte E. Ariyan
    Alexander N. Shoushtari
    Vinod P. Balachandran
    A. Ari Hakimi
    Aimee M. Crago
    Kara C. Long Roche
    J. Joshua Smith
    Ian Ganly
    Richard J. Wong
    Snehal G. Patel
    Jatin P. Shah
    Nancy Y. Lee
    Nadeem Riaz
    Jingming Wang
    Ahmet Zehir
    Michael F. Berger
    Timothy A. Chan
    Venkatraman E. Seshan
    Luc G. T. Morris
    [J]. Nature Communications, 12
  • [30] Successful response to monotherapy of immune checkpoint inhibitor in intrahepatic cholangiocarcinoma with high tumor mutational burden and PD-L1 expression
    Li, Yunfeng
    Hu, Maitao
    Li, Lei
    Liu, Sheng
    He, Tingting
    Cheng, Chunyan
    Xu, Mian
    Yin, Xinmin
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (01)
12345